To confirm the role of EP4 in hypo-MSC mediated HCC progression, we used EP4 agonist, Cay10598, to activate EP4 in HCC cells, and found YAP was also activated (Fig. 6d, e). This evidence concerns the gene PTGER4 and hepatocellular carcinoma.